HomeTTI • CVE
add
Thiogenesis Therapeutics Corp
Nakaraang pagsara
$0.73
Sakop ng araw
$0.70 - $0.73
Sakop ng taon
$0.51 - $0.80
Market cap
33.80M CAD
Average na Volume
29.04K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (CAD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 1.32M | -38.07% |
Net na kita | -1.13M | 45.59% |
Net profit margin | — | — |
Kita sa bawat share | — | — |
EBITDA | — | — |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CAD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 3.85M | -45.62% |
Kabuuang asset | 3.98M | -45.00% |
Kabuuang sagutin | 557.88K | -67.43% |
Kabuuang equity | 3.43M | — |
Natitirang share | 45.76M | — |
Presyo para makapag-book | 10.43 | — |
Return on assets | -79.91% | — |
Return on capital | -86.92% | — |
Cash Flow
Net change in cash
| (CAD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -1.13M | 45.59% |
Cash mula sa mga operasyon | -538.58K | 22.69% |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | 253.90K | -93.84% |
Net change in cash | -299.15K | -108.68% |
Malayang cash flow | -583.36K | -1,362.06% |
Tungkol
Itinatag
2018
Headquarters
Website
